Deutsche Bank Ag\ Lyra Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$4.22 - $9.41 $322,205 - $718,472	-76,352 Closed	0 $0
Q3 2021 Nov 04, 2021	SELL	$6.06 - $9.43 $539 - $839	-89 Reduced 0.12%	76,352 $697,000
Q2 2021 Aug 11, 2021	SELL	$6.91 - $12.59 $30,113 - $54,867	-4,358 Reduced 5.39%	76,441 $614,000
Q1 2021 May 13, 2021	BUY	$10.38 - $15.61 $789,160 - $1.19 Million	76,027 Added 1593.19%	80,799 $936,000
Q4 2020 Feb 16, 2021	BUY	$9.28 - $13.88 $24,916 - $37,267	2,685 Added 128.65%	4,772 $54,000
Q3 2020 Nov 12, 2020	BUY	$10.61 - $13.96 $2,079 - $2,736	196 Added 10.36%	2,087 $23,000
Q2 2020 Aug 13, 2020	BUY	$10.91 - $18.56 $20,630 - $35,096	1,891 New	1,891 $21,000

32.2M

21.1K

400

Ticker LYRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,826,400
Market Cap $6.68M
Description
Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.